top of page


PAVILION OF COMPANIES
Interesting discussions with Visionaries, Entrepreneurs, CEOs, and Smart Business people!
Pavilion

NeuroRX
2015
More than 500 people with bipolar disease die each day from suicidal crisis across the OECD countries. NeuroRx has demonstrated human proof of concept for a first-in-class, rapid-onset, sustained therapy for this condition, which currently has no approved treatment.
bottom of page